safety evaluation of crocin (a constituent of saffron) tablets in healthy volunteers

Authors

amir houshang mohamadpour 1pharmaceutical research center, department of pharmacodynamy and toxicology, school of pharmacy, mashhad university of medical sciences, mashhad, iran

zahara ayati 2department of pharmacodynamy and toxicology, school of pharmacy, mashhad university of medical sciences, mashhad, iran

mohammad–reza parizadeh 2department of pharmacodynamy and toxicology, school of pharmacy, mashhad university of medical sciences, mashhad, iran

omid rajbai 2department of pharmacodynamy and toxicology, school of pharmacy, mashhad university of medical sciences, mashhad, iran

abstract

objective(s): crocin is the chemical ingredient primarily responsible for the color of saffron. it has different pharmacological effects such as antioxidant, anticancer and memory improving activities. crocin tablets were evaluated for short-term safety and tolerability in healthy adult volunteers. materials and methods: the study was a randomized, double-blind, placebo-controlled design consisting of one month treatment of crocin tablets. volunteers who fulfilled inclusion and exclusion criteria were randomized into 2 groups of 22 each (males and females) and received 20 mg crocin tablets or placebo. general measures of health were recorded during the study such as hematological, biochemical, hormonal and urinary parameters in pre and post-treatment periods. results: no major adverse events were reported during the trial. crocin tablets did not change the above parameters except that it decreased amylase, mixed white blood cells and ptt in healthy volunteers after one month. conclusion: this clinical safety evaluation showed a relatively safe and normal profile for crocin in healthy volunteers at the given doses within the trial period.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers

Objective(s): Crocin is the chemical ingredient primarily responsible for the color of saffron. It has different pharmacological effects such as antioxidant, anticancer and memory improving activities. Crocin tablets were evaluated for short-term safety and tolerability in healthy adult volunteers. Materials and Methods: The study was a randomized, double-blind, placebo-controlled design consis...

full text

Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers.

Saffron (Crocus sativus) stigma tablets were evaluated for short-term safety and tolerability in healthy adult volunteers. The study was a double-blind, placebo-controlled design consisting of a 1 week treatment of saffron tablets. Volunteers were divided into 3 groups of 10 each (5 males and 5 females). Group I received placebo; groups 2 and 3 received 200 and 400mg saffron tablets, respective...

full text

Evaluation of the Diuretic Effects of Crocin (active Constituent of Saffron) in Rats

Aim of this study is to confirm and investigate the diuretic effect of crocine which is the pharmacologically active component of Crocus sativus L. (saffron) and to study the possible mechanism of action in relation to urinary nitrite. Twenty four rats were divided into 3 groups; control, hydrochlorothiazide and crocine treated groups. Assay of the diuretic activity of crocine was performed by ...

full text

Evaluation of the Diuretic Effects of Crocin (active Constituent of Saffron) in Rats

Aim of this study is to confirm and investigate the diuretic effect of crocine which is the pharmacologically active component of Crocus sativus L. (saffron) and to study the possible mechanism of action in relation to urinary nitrite. Twenty four rats were divided into 3 groups; control, hydrochlorothiazide and crocine treated groups. Assay of the diuretic activity of crocine was performed by ...

full text

Comparative Bioavailability of Ranitidine Tablets in Healthy Volunteers

The pharmacokinetic parameters of domestic and imported ranitidine hydrochloride tablets (Ranitidine, formulated and manufactured by Kharazmi Pharmaceuticals, Iran, and Zantac ? manufactured by Glaxo, UK) were measured in 14 healthy subjects following oral administration of a single 300-mg dose of each brand and compared for bioequivalence evaluation. The pharmaceutical equivalency of both fo...

full text

Comparative Bioavailability of Ranitidine Tablets in Healthy Volunteers

The pharmacokinetic parameters of domestic and imported ranitidine hydrochloride tablets (Ranitidine, formulated and manufactured by Kharazmi Pharmaceuticals, Iran, and Zantac ? manufactured by Glaxo, UK) were measured in 14 healthy subjects following oral administration of a single 300-mg dose of each brand and compared for bioequivalence evaluation. The pharmaceutical equivalency of both fo...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of basic medical sciences

جلد ۱۶، شماره ۱، صفحات ۳۹-۴۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023